Stock A241820 PCL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News PCL, Inc.

Equities

A241820

KR7241820000

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 06/05/2024 BST 		5-day change 1st Jan Change
1,185 KRW 0.00% Intraday chart for PCL, Inc. -1.50% -66.95%
01-16 PCL, Inc. announced that it has received KRW 9.99999885 billion in funding from Global Emerging Markets CI
2023 PCL, Inc. announced that it has received KRW 9.99999838 billion in funding from Global Emerging Markets CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PCL, Inc. announced that it has received KRW 9.99999885 billion in funding from Global Emerging Markets
CI
PCL, Inc. announced that it has received KRW 9.99999838 billion in funding from Global Emerging Markets
CI
PCL, Inc. announced that it expects to receive KRW 9.99999885 billion in funding from Global Emerging Markets
CI
PCL, Inc. announced that it expects to receive KRW 9.99999838 billion in funding from Global Emerging Markets
CI
South Korean Stocks Close Lower as Uncertainties Around US Debt Ceiling Deal Remain; PCL Loses 13%
MT
PCL to Raise 36 Billion Won via Share Issuance
MT
PCL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
PCL, Inc. announced that it has received KRW 2.999990812 billion in funding from Hyeopsim Co ., Ltd.
CI
PCL to Raise 3 Billion Won via Share Issuance; Shares Jump 4%
MT
PCL, Inc. announced that it expects to receive KRW 2.999990812 billion in funding from Hyeopsim Co ., Ltd.
CI
PCL, Inc. terminated the acquisition of 40.76% stake in mCureX Therapeutics, Inc. from OliX Pharmaceuticals, Inc, Samyang Holdings Corporation, AJU Good Growth Support Fund managed by Aju IB Investment Co., Ltd. and Kiwoom New Hero Fund I managed by Kiwoom Investment Co., Ltd.
CI
PCL, Inc. announced that it has received KRW 12.060247575 billion in funding
CI
OliX Pharmaceuticals, Inc agreed to acquire 6.63% stake in PCL, Inc. for KRW8.04 billion.
CI
PCL, Inc. agreed to acquire unknown minority stake in stake in mCureX Therapeutics, Inc. from OliX Pharmaceuticals, Inc, Samyang Holdings Corporation, AJU Good Growth Support Fund managed by Aju IB Investment Co., Ltd. and Kiwoom New Hero Fund I managed by Kiwoom Investment Co., Ltd. for KRW12.2 billion.
CI
PCL, Inc.(KOSDAQ:A241820) dropped from S&P Global BMI Index
CI
PCL, Inc.(KOSDAQ:A241820) added to S&P Global BMI Index
CI
MCureX Therapeutics, Inc. announced that it expects to receive KRW 2 billion in funding from OliX Pharmaceuticals,Inc, PCL, Inc., Samyang Holdings Corporation
CI
PCL, Inc. announced that it has received KRW 40.499938368 billion in funding from a group of investors
CI
Datametrex AI Limited Secures Authorization by Health Canada for PCL Inc.'s COVID19 Rapid Antigen Test Kit
CI
PCL, Inc. announced that it expects to receive KRW 40.499938368 billion in funding from a group of investors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A241820 Stock
  4. News PCL, Inc.